Patent · US Active

Human monoclonal antibodies to O8E

US8609816B2 · kind B2 · utility

8Cited by
32References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 8, 2006
Grant dateDec 17, 2013
Priority date
Expiry dateFeb 1, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N15/62
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to O8E with high affinity. Nucleic acid molecules encoding the antibodies of this disclosure, expression vectors, host cells and methods for expressing the antibodies of this disclosure are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of this disclosure are also provided. This disclosure also provides methods for treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.